Company Epigenomics AG Xetra
Equities
DE000A1K0516
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
Apr. 30 | Epigenomics AG Announces Jens Ravens Leaves as Executive Board Member | CI |
Mar. 14 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
In Vitro Diagnostic - Products
95.9
%
| 0 | 7.5 % | 0 | 95.9 % | 0.00% |
Licensing
4.1
%
| 0 | 0.4 % | 0 | 4.1 % | -9.09% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
North America
54.2
%
| 0 | 4.8 % | 0 | 54.2 % | -11.45% |
Europe
38.6
%
| 0 | 3.0 % | 0 | 38.6 % | -1.06% |
Asia
7.2
%
| 6 | 92.2 % | 0 | 7.2 % | -99.39% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
Annett Dietrich
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Helge Lubenow
CHM | Chairman | 56 | 16-05-24 |
Jochen Hummel
BRD | Director/Board Member | 54 | Feb. 04 |
Alexander Link
BRD | Director/Board Member | 53 | 20-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 875,150 | 584,339 ( 66.77 %) | 0 | 66.77 % |
Company contact information
![address Epigenomics AG](https://cdn.zonebourse.com/static/address/8586258.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-39.58% | 8.36B | |
+10.20% | 3.38B | |
+4.34% | 2.18B | |
-25.96% | 1.82B | |
-17.74% | 1.64B | |
+29.69% | 1.03B | |
+29.92% | 752M | |
-12.01% | 689M | |
-20.92% | 516M |
- Stock Market
- Equities
- ECX Stock
- Stock
- Company Epigenomics AG